Endoscopic dacryocystorhinostomy (DCR) is a well-established alternative to
external DCR for treatment of obstruction of the lacrimal pathway and has
a success rate of up to 95% in primary cases. Despite the benefits of using
an endoscopic approach, including enhanced intranasal access to the lacrim
al drainage system, there still exists a significant failure rate, particul
arly in revision procedures. As these failures are mainly due to obstructiv
e postoperative adhesions, intraoperative adjuncts that prevent or minimize
scarring should enhance the success rate. Endoscopic DCR was performed wit
h intraoperative topical application of mitomycin-C, an antimetabolite ofte
n used in ophthalmologic procedures to reduce scarring and formation of adh
esions following surgery. The procedure tvas successful in 7 of 8 instances
, with a follow-up of 3 to 27 months. In one procedure, obstruction recurre
d 10 weeks after surgery. We feel that the results of this small series are
encouraging and that further studies are warranted to determine the effect
iveness of mitomycin-C as an adjunct to endoscopic DCR.